{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T12:29:54Z","timestamp":1794745794946,"version":"4.9.1"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T00:00:00Z","timestamp":1730073600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["metabolismjournal.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.metabol.2024.156051","type":"journal-article","created":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T15:47:01Z","timestamp":1729698421000},"page":"156051","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Impaired unsaturated fatty acid elongation alters mitochondrial function and accelerates metabolic dysfunction-associated steatohepatitis progression"],"prefix":"10.1016","volume":"162","author":[{"given":"Adrien","family":"Vouilloz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thibaut","family":"Bourgeois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Diedisheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Pilot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Jalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naig","family":"Le Guern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Bergas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"No\u00e9line","family":"Rohmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Castelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Leleu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Varin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Paul Pais","family":"de Barros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Degrace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mickael","family":"Rialland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Bl\u00e9riot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Venteclef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Masson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.metabol.2024.156051_bb0005","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.metabol.2024.156051_bb0010","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.metabol.2024.156051_bb0015","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1002\/hep.21763","article-title":"A lipidomic analysis of nonalcoholic fatty liver disease","volume":"46","author":"Puri","year":"2007","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.metabol.2024.156051_bb0020","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jhep.2007.09.009","article-title":"Nutritional assessment and hepatic fatty acid composition in non-alcoholic fatty liver disease (NAFLD): a cross-sectional study","volume":"48","author":"Allard","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.metabol.2024.156051_bb0025","first-page":"62","article-title":"Nonalcoholic fatty liver disease stratification by liver lipidomics","author":"Vvedenskaya","year":"2021","journal-title":"J Lipid Res"},{"issue":"3","key":"10.1016\/j.metabol.2024.156051_bb0030","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1194\/jlr.P056002","article-title":"Biomarkers of NAFLD progression: a lipidomics approach to an epidemic","volume":"56","author":"Gorden","year":"2015","journal-title":"J Lipid Res"},{"key":"10.1016\/j.metabol.2024.156051_bb0035","doi-asserted-by":"crossref","unstructured":"Tian Y, Jellinek MJ, Mehta K, et al. Membrane phospholipid remodeling modulates nonalcoholic steatohepatitis progression by regulating mitochondrial homeostasis. Hepatology. Published online April 1, 2023. doi:https:\/\/doi.org\/10.1097\/HEP.0000000000000375.","DOI":"10.1097\/HEP.0000000000000375"},{"key":"10.1016\/j.metabol.2024.156051_bb0040","doi-asserted-by":"crossref","unstructured":"Tian Y, Wang B. Unraveling the pathogenesis of non-alcoholic fatty liver diseases through genome-wide association studies. J Gastroenterol Hepatol. Published online August 17, 2023. doi:https:\/\/doi.org\/10.1111\/jgh.16330.","DOI":"10.1111\/jgh.16330"},{"issue":"2","key":"10.1016\/j.metabol.2024.156051_bb0045","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/MCO.0b013e328342991c","article-title":"Fatty acid regulation of hepatic lipid metabolism","volume":"14","author":"Jump","year":"2011","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"1","key":"10.1016\/j.metabol.2024.156051_bb0050","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1194\/jlr.M028787","article-title":"Elovl5 regulates the mTORC2-Akt-FOXO1 pathway by controlling hepatic cis-vaccenic acid synthesis in diet-induced obese mice","volume":"54","author":"Tripathy","year":"2013","journal-title":"J Lipid Res"},{"issue":"Pt 3","key":"10.1016\/j.metabol.2024.156051_bb0055","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1042\/bj3500765","article-title":"Cloning of a human cDNA encoding a novel enzyme involved in the elongation of long-chain polyunsaturated fatty acids","volume":"350 Pt 3","author":"Leonard","year":"2000","journal-title":"Biochem J"},{"issue":"2","key":"10.1016\/j.metabol.2024.156051_bb0060","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.plipres.2009.12.002","article-title":"The key roles of elongases and desaturases in mammalian fatty acid metabolism: insights from transgenic mice","volume":"49","author":"Guillou","year":"2010","journal-title":"Prog Lipid Res"},{"issue":"9","key":"10.1016\/j.metabol.2024.156051_bb0065","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1194\/jlr.M600177-JLR200","article-title":"Regulation of hepatic fatty acid elongase and desaturase expression in diabetes and obesity","volume":"47","author":"Wang","year":"2006","journal-title":"J Lipid Res"},{"issue":"3","key":"10.1016\/j.metabol.2024.156051_bb0070","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1194\/jlr.M800383-JLR200","article-title":"Deletion of ELOVL5 leads to fatty liver through activation of SREBP-1c in mice","volume":"50","author":"Moon","year":"2009","journal-title":"J Lipid Res"},{"issue":"7","key":"10.1016\/j.metabol.2024.156051_bb0075","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1194\/jlr.M050062","article-title":"Fatty acid elongase-5 (Elovl5) regulates hepatic triglyceride catabolism in obese C57BL\/6J mice","volume":"55","author":"Tripathy","year":"2014","journal-title":"J Lipid Res"},{"issue":"7","key":"10.1016\/j.metabol.2024.156051_bb0080","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1194\/jlr.M800123-JLR200","article-title":"Elevated hepatic fatty acid elongase-5 activity affects multiple pathways controlling hepatic lipid and carbohydrate composition","volume":"49","author":"Wang","year":"2008","journal-title":"J Lipid Res"},{"issue":"2","key":"10.1016\/j.metabol.2024.156051_bb0085","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.bbalip.2008.12.003","article-title":"Regulation of hepatic fatty acid elongase 5 by LXRalpha-SREBP-1c","volume":"1791","author":"Qin","year":"2009","journal-title":"Biochim Biophys Acta"},{"issue":"15","key":"10.1016\/j.metabol.2024.156051_bb0090","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20153787","article-title":"Revisiting the role of LXRs in PUFA metabolism and phospholipid homeostasis","volume":"20","author":"Jalil","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.metabol.2024.156051_bb0095","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1161\/ATVBAHA.115.305539","article-title":"Liver X receptor activation promotes polyunsaturated fatty acid synthesis in macrophages: relevance in the context of atherosclerosis","volume":"35","author":"Varin","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"9","key":"10.1016\/j.metabol.2024.156051_bb0100","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1194\/jlr.M600177-JLR200","article-title":"Regulation of hepatic fatty acid elongase and desaturase expression in diabetes and obesity","volume":"47","author":"Wang","year":"2006","journal-title":"J Lipid Res"},{"issue":"49","key":"10.1016\/j.metabol.2024.156051_bb0105","doi-asserted-by":"crossref","first-page":"34036","DOI":"10.1074\/jbc.M109.051052","article-title":"Fenofibrate simultaneously induces hepatic fatty acid oxidation, synthesis, and elongation in mice","volume":"284","author":"Oosterveer","year":"2009","journal-title":"J Biol Chem"},{"issue":"9","key":"10.1016\/j.metabol.2024.156051_bb0110","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1111\/apt.16022","article-title":"Fatty acid composition of the erythrocyte membrane and risk of hepatocellular carcinoma in cirrhotic patients","volume":"52","author":"Mouillot","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.metabol.2024.156051_bb0115","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.2337\/db14-1220","article-title":"Imeglimin normalizes glucose tolerance and insulin sensitivity and improves mitochondrial function in liver of a high-fat, high-sucrose diet mice model","volume":"64","author":"Vial","year":"2015","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.metabol.2024.156051_bb0120","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/s41597-021-01095-3","article-title":"ProMetIS, deep phenotyping of mouse models by combined proteomics and metabolomics analysis","volume":"8","author":"Imbert","year":"2021","journal-title":"Sci Data"},{"key":"10.1016\/j.metabol.2024.156051_bb0125","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jchromb.2014.04.025","article-title":"Annotation of the human serum metabolome by coupling three liquid chromatography methods to high-resolution mass spectrometry","volume":"966","author":"Boudah","year":"2014","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"3","key":"10.1016\/j.metabol.2024.156051_bb0130","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s11306-007-0082-2","article-title":"Proposed minimum reporting standards for chemical analysis Chemical Analysis Working Group (CAWG) Metabolomics Standards Initiative (MSI)","volume":"3","author":"Sumner","year":"2007","journal-title":"Metabolomics"},{"issue":"1","key":"10.1016\/j.metabol.2024.156051_bb0135","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/nar\/28.1.27","article-title":"KEGG: Kyoto encyclopedia of genes and genomes","volume":"28","author":"Kanehisa","year":"2000","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"10.1016\/j.metabol.2024.156051_bb0140","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1097\/01.ftd.0000179845.53213.39","article-title":"METLIN: a metabolite mass spectral database","volume":"27","author":"Smith","year":"2005","journal-title":"Ther Drug Monit"},{"issue":"Database issue","key":"10.1016\/j.metabol.2024.156051_bb0145","doi-asserted-by":"crossref","first-page":"D521","DOI":"10.1093\/nar\/gkl923","article-title":"HMDB: the human metabolome database","volume":"35","author":"Wishart","year":"2007","journal-title":"Nucleic Acids Res"},{"issue":"7","key":"10.1016\/j.metabol.2024.156051_bb0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1003123","article-title":"Predicting network activity from high throughput metabolomics","volume":"9","author":"Li","year":"2013","journal-title":"PLoS Comput Biol"},{"issue":"12","key":"10.1016\/j.metabol.2024.156051_bb0155","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1101\/gr.251983.119","article-title":"Identifying gene function and module connections by the integration of multispecies expression compendia","volume":"29","author":"Li","year":"2019","journal-title":"Genome Res"},{"key":"10.1016\/j.metabol.2024.156051_bb0160","doi-asserted-by":"crossref","unstructured":"Gribben C, Galanakis V, Calderwood A, et al. Acquisition of epithelial plasticity in human chronic liver disease. Nature. Published online May 22, 2024. doi:https:\/\/doi.org\/10.1038\/s41586-024-07465-2.","DOI":"10.1038\/s41586-024-07465-2"},{"issue":"2","key":"10.1016\/j.metabol.2024.156051_bb0165","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41587-023-01767-y","article-title":"Dictionary learning for integrative, multimodal and scalable single-cell analysis","volume":"42","author":"Hao","year":"2024","journal-title":"Nat Biotechnol"},{"issue":"572","key":"10.1016\/j.metabol.2024.156051_bb0170","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aba4448","article-title":"Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis","volume":"12","author":"Govaere","year":"2020","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.metabol.2024.156051_bb0175","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.pharmthera.2017.07.007","article-title":"Omega-3 polyunsaturated fatty acids as a treatment strategy for nonalcoholic fatty liver disease","volume":"181","author":"Jump","year":"2018","journal-title":"Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.metabol.2024.156051_bb0180","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.jhep.2011.08.018","article-title":"Omega-3 supplementation and non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"56","author":"Parker","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.metabol.2024.156051_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2021.100073","article-title":"The lipidome in nonalcoholic fatty liver disease: actionable targets","volume":"62","author":"Pirola","year":"2021","journal-title":"J Lipid Res"},{"issue":"4","key":"10.1016\/j.metabol.2024.156051_bb0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0214387","article-title":"Lipidomic and transcriptomic analysis of western diet-induced nonalcoholic steatohepatitis (NASH) in female Ldlr \u2212\/\u2212 mice","volume":"14","author":"Garcia-Jaramillo","year":"2019","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.metabol.2024.156051_bb0195","doi-asserted-by":"crossref","DOI":"10.1038\/srep46658","article-title":"Metabolism dysregulation induces a specific lipid signature of nonalcoholic steatohepatitis in patients","volume":"7","author":"Chiappini","year":"2017","journal-title":"Sci Rep"},{"issue":"10","key":"10.1016\/j.metabol.2024.156051_bb0200","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1007\/s00125-013-2981-2","article-title":"Prediction of non-alcoholic fatty-liver disease and liver fat content by serum molecular lipids","volume":"56","author":"Ore\u0161i\u010d","year":"2013","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2024.156051_bb0205","doi-asserted-by":"crossref","DOI":"10.1177\/1756284820923904","article-title":"Plasma eicosanoids as noninvasive biomarkers of liver fibrosis in patients with nonalcoholic steatohepatitis","volume":"13","author":"Caussy","year":"2020","journal-title":"Therap Adv Gastroenterol"},{"issue":"10","key":"10.1016\/j.metabol.2024.156051_bb0210","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1007\/s00125-014-3310-0","article-title":"PNPLA3 variant I148M is associated with altered hepatic lipid composition in humans","volume":"57","author":"Peter","year":"2014","journal-title":"Diabetologia"},{"issue":"3","key":"10.1016\/j.metabol.2024.156051_bb0215","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.jhep.2020.04.021","article-title":"MARC1 variant rs2642438 increases hepatic phosphatidylcholines and decreases severity of non-alcoholic fatty liver disease in humans","volume":"73","author":"Luukkonen","year":"2020","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.metabol.2024.156051_bb0220","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jhep.2017.02.014","article-title":"Impaired hepatic lipid synthesis from polyunsaturated fatty acids in TM6SF2 E167K variant carriers with NAFLD","volume":"67","author":"Luukkonen","year":"2017","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.metabol.2024.156051_bb0225","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/s41588-022-01078-z","article-title":"A multiancestry genome-wide association study of unexplained chronic ALT elevation as a proxy for nonalcoholic fatty liver disease with histological and radiological validation","volume":"54","author":"Vujkovic","year":"2022","journal-title":"Nat Genet"},{"issue":"6","key":"10.1016\/j.metabol.2024.156051_bb0230","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1002\/hep.25932","article-title":"Elovl6 promotes nonalcoholic steatohepatitis","volume":"56","author":"Matsuzaka","year":"2012","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.metabol.2024.156051_bb0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mito.2005.10.004","article-title":"Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it","volume":"6","author":"Begriche","year":"2006","journal-title":"Mitochondrion"},{"issue":"10","key":"10.1016\/j.metabol.2024.156051_bb0240","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1194\/jlr.M085613","article-title":"Mitochondrial dysfunction-related lipid changes occur in nonalcoholic fatty liver disease progression","volume":"59","author":"Peng","year":"2018","journal-title":"J Lipid Res"},{"issue":"7","key":"10.1016\/j.metabol.2024.156051_bb0245","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1194\/jlr.M004747","article-title":"Role of fatty acid elongases in determination of de novo synthesized monounsaturated fatty acid species","volume":"51","author":"Green","year":"2010","journal-title":"J Lipid Res"},{"key":"10.1016\/j.metabol.2024.156051_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2021.100111","article-title":"Fatty acyl availability modulates cardiolipin composition and alters mitochondrial function in HeLa cells","volume":"62","author":"Oemer","year":"2021","journal-title":"J Lipid Res"},{"issue":"1","key":"10.1016\/j.metabol.2024.156051_bb0255","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/S1674-8301(10)60003-6","article-title":"Emerging roles of cardiolipin remodeling in mitochondrial dysfunction associated with diabetes, obesity, and cardiovascular diseases","volume":"24","author":"Shi","year":"2010","journal-title":"J Biomed Res"},{"issue":"3","key":"10.1016\/j.metabol.2024.156051_bb0260","doi-asserted-by":"crossref","first-page":"559","DOI":"10.3390\/nu14030559","article-title":"Elovl2-ablation leads to mitochondrial membrane fatty acid remodeling and reduced efficiency in mouse liver mitochondria","volume":"14","author":"G\u00f3mez Rodr\u00edguez","year":"2022","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.metabol.2024.156051_bb0265","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.cmet.2010.07.003","article-title":"Cardiolipin remodeling by ALCAT1 links oxidative stress and mitochondrial dysfunction to obesity","volume":"12","author":"Li","year":"2010","journal-title":"Cell Metab"},{"issue":"2","key":"10.1016\/j.metabol.2024.156051_bb0270","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/hep.27420","article-title":"ALCAT1 controls mitochondrial etiology of fatty liver diseases, linking defective mitophagy to hepatosteatosis","volume":"61","author":"Wang","year":"2015","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.metabol.2024.156051_bb0275","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/j.cgh.2023.03.041","article-title":"Clinical trial landscape in NASH","volume":"21","author":"Harrison","year":"2023","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049524002798?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049524002798?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T10:18:38Z","timestamp":1733825918000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049524002798"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":55,"alternative-id":["S0026049524002798"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2024.156051","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impaired unsaturated fatty acid elongation alters mitochondrial function and accelerates metabolic dysfunction-associated steatohepatitis progression","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2024.156051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"156051"}}